165 related articles for article (PubMed ID: 28948567)
1. Regulatory Notes on Impact of Excipients on Drug Products and the Maillard Reaction.
Chowdhury DK; Sarker H; Schwartz P
AAPS PharmSciTech; 2018 Feb; 19(2):965-969. PubMed ID: 28948567
[TBL] [Abstract][Full Text] [Related]
2. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine.
Wirth DD; Baertschi SW; Johnson RA; Maple SR; Miller MS; Hallenbeck DK; Gregg SM
J Pharm Sci; 1998 Jan; 87(1):31-9. PubMed ID: 9452965
[TBL] [Abstract][Full Text] [Related]
3. Modification of pharmacological activity of nebivolol due to Maillard reaction.
Patil DD; Patil CR
Pharm Dev Technol; 2013; 18(4):844-51. PubMed ID: 23668372
[TBL] [Abstract][Full Text] [Related]
4. Effect of milling and compression on the solid-state Maillard reaction.
Qiu Z; Stowell JG; Cao W; Morris KR; Byrn SR; Carvajal MT
J Pharm Sci; 2005 Nov; 94(11):2568-80. PubMed ID: 16200560
[TBL] [Abstract][Full Text] [Related]
5. Are Excipients Inert? Phenytoin Pharmaceutical Investigations with New Incompatibility Insights.
Amaral Silva D; Löbenberg R; Davies NM
J Pharm Pharm Sci; 2018; 21(1s):29745. PubMed ID: 29702046
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea-Lactose Interaction Study: In Silico and In Vitro Evaluation.
Bachchhao KB; Patil RR; Patil CR; Patil DD
AAPS PharmSciTech; 2017 Nov; 18(8):3034-3041. PubMed ID: 28500485
[TBL] [Abstract][Full Text] [Related]
7. Identification, synthesis, isolation and characterization of formulation related impurity of Gabapentin.
Reddy RB; More KR; Jha MS; Sharma B; Magar L
J Pharm Biomed Anal; 2016 Sep; 129():509-513. PubMed ID: 27497652
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
[TBL] [Abstract][Full Text] [Related]
10. The Maillard reaction of bisoprolol fumarate with various reducing carbohydrates.
Szalka M; Lubczak J; Naróg D; Laskowski M; Kaczmarski K
Eur J Pharm Sci; 2014 Aug; 59():1-11. PubMed ID: 24746680
[TBL] [Abstract][Full Text] [Related]
11. The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations.
Djordjević Filijović N; Antonijević MD; Pavlović A; Vučković I; Nikolić K; Agbaba D
Drug Dev Ind Pharm; 2015 Mar; 41(3):502-14. PubMed ID: 24611817
[TBL] [Abstract][Full Text] [Related]
12. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
13. Characterizing Maillard reaction kinetics and rheological changes in white chocolate over extended heating.
Rodier LC; Hartel RW
J Food Sci; 2021 Jun; 86(6):2553-2568. PubMed ID: 34056726
[TBL] [Abstract][Full Text] [Related]
14. Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development.
Kushner J
Pharm Dev Technol; 2013; 18(2):333-42. PubMed ID: 21877870
[TBL] [Abstract][Full Text] [Related]
15. Amlodipine besylate-excipients interaction in solid dosage form.
Abdoh A; Al-Omari MM; Badwan AA; Jaber AM
Pharm Dev Technol; 2004; 9(1):15-24. PubMed ID: 15000463
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical analysis and nonisothermal kinetic study of sertraline-lactose binary mixtures.
Ghaderi F; Nemati M; Siahi-Shadbad MR; Valizadeh H; Monajjemzadeh F
J Food Drug Anal; 2017 Jul; 25(3):709-716. PubMed ID: 28911656
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
[TBL] [Abstract][Full Text] [Related]
18. Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms.
Kubbinga M; Moghani L; Langguth P
Eur J Pharm Sci; 2014 Sep; 61():27-31. PubMed ID: 24732384
[TBL] [Abstract][Full Text] [Related]
19. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
[TBL] [Abstract][Full Text] [Related]
20. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
